RJA
PAHC icon

Raymond James & Associates’s Phibro Animal Health PAHC Stock Holding History

Raymond James & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-78,152
Closed -$1.5M – 4091
2022
Q2 		$1.5M Buy
78,152
+1,077
+1% +$20.4K ﹤0.01% 2192
2022
Q1 		$1.54M Buy
77,075
+5,274
+7% +$107K ﹤0.01% 2308
2021
Q4 		$1.47M Sell
71,801
-6,311
-8% -$135K ﹤0.01% 2378
2021
Q3 		$1.68M Sell
78,112
-789
-1% -$19K ﹤0.01% 2221
2021
Q2 		$2.28M Sell
78,901
-1,656
-2% -$44.8K ﹤0.01% 2007
2021
Q1 		$1.97M Buy
80,557
+2,165
+3% +$48.9K ﹤0.01% 2027
2020
Q4 		$1.52M Sell
78,392
-105,597
-57% -$1.94M ﹤0.01% 2063
2020
Q3 		$3.2M Sell
183,989
-9,092
-5% -$194K ﹤0.01% 1471
2020
Q2 		$5.07M Buy
193,081
+26,354
+16% +$654K 0.01% 1175
2020
Q1 		$4.03M Buy
166,727
+98,240
+143% +$2.4M 0.01% 1164
2019
Q4 		$1.7M Buy
+68,487
New +$1.59M ﹤0.01% 1921
2018
Q4 		– Sell
-4,849
Closed -$208K – 3655
2018
Q3 		$208K Buy
+4,849
New +$229K ﹤0.01% 3268

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raymond James & Associates's PAHC Position: Q3 2022 in Review

Raymond James & Associates sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 78,152 shares — an estimated $1.5M sold.

Raymond James & Associates first reported a position in PAHC in Q3 2018 and held it in 12 quarters. The position peaked at $5.07M in Q2 2020. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • Raymond James & Associates reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 78,152 Phibro Animal Health shares in Q3 2022, an estimated $1.5M.
  • Raymond James & Associates first reported a position in Phibro Animal Health in Q3 2018 and held it in 12 quarters.
  • Raymond James & Associates's Phibro Animal Health position peaked at $5.07M in Q2 2020.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.